Back to search
FDAFDA · Food and drugs·Recall number D-0387-2021

Dry Eye Test, Fluorescein Sodium, Ophthalmic Strips USP (0.12mg Fluorescein Sodium), 100 Sterile Strips (50 Pouches of 2 Strips Each), Manufactured by: Nomax, Inc, St. Louis, MO 63123, NDC: 51801-008-15

Published May 26, 2021 · Recall initiated: April 13, 2021

Summary

FDA records drug Class III recall D-0387-2021, published May 26, 2021 and initiated April 13, 2021. Recalling firm: Nomax Inc; Status: Terminated; Reported quantity: 78 cartons; Lot: LOT 13336 EXP 07/23. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug

What to do

Voluntary: Firm initiated · Letter

Get an email if DRY EYE TEST has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DRY EYE TEST
Manufacturer
Nomax Inc
Distributor
Nationwide USA
Lot
LOT 13336 EXP 07/23
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dry Eye Test, Fluorescein Sodium, Ophthalmic Strips USP (0.12mg Fluorescein Sodium), 100 Sterile Strips (50 Pouches of 2 Strips Each), Manufactured by: Nomax, Inc, St. Louis, MO 63123, NDC: 51801-008-15 recalled?

Yes. FDA published recall D-0387-2021 on May 26, 2021. Reported hazard: Subpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DRY EYE TEST.